Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8643104rdf:typepubmed:Citationlld:pubmed
pubmed-article:8643104lifeskim:mentionsumls-concept:C0020204lld:lifeskim
pubmed-article:8643104lifeskim:mentionsumls-concept:C1327616lld:lifeskim
pubmed-article:8643104lifeskim:mentionsumls-concept:C0021036lld:lifeskim
pubmed-article:8643104lifeskim:mentionsumls-concept:C2828389lld:lifeskim
pubmed-article:8643104pubmed:issue17-18lld:pubmed
pubmed-article:8643104pubmed:dateCreated1996-7-15lld:pubmed
pubmed-article:8643104pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:abstractTextAn anti-DNA hybridoma derived from an MRL/lpr mouse secretes two different kappa light chains in combination with a single heavy chain. Multiple single cell clones express and secrete immunoglobulin containing both kappa light chains. The N-terminal protein sequences of the light chains correspond to sequences predicted from functionally rearranged mRNAs subjected to reverse transcription and amplified by polymerase chain reaction (PCR). Karyotype analysis of the hybridoma indicates a clonal line derived from the fusion of two cells. By amino acid sequence comparison and PCR analysis, both functional kappa light chains are derived from the MRL/lpr spleen. The two functional light chain cDNAs were cloned and co-transfected into COS-7 cells with the heavy chain cDNA. Only one of the light chains in combination with mAb 3E10 heavy chain confers anti-DNA reactivity. The presence of two separate kappa light chains and, therefore, two separate antigen receptors on a single B cell may have ramifications for both polyclonal activation and toleration of lupus B cells.lld:pubmed
pubmed-article:8643104pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:languageenglld:pubmed
pubmed-article:8643104pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:citationSubsetIMlld:pubmed
pubmed-article:8643104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8643104pubmed:statusMEDLINElld:pubmed
pubmed-article:8643104pubmed:monthDeclld:pubmed
pubmed-article:8643104pubmed:issn0161-5890lld:pubmed
pubmed-article:8643104pubmed:authorpubmed-author:WeisbartR HRHlld:pubmed
pubmed-article:8643104pubmed:authorpubmed-author:WongA LALlld:pubmed
pubmed-article:8643104pubmed:authorpubmed-author:StempniakMMlld:pubmed
pubmed-article:8643104pubmed:authorpubmed-author:ZackD JDJlld:pubmed
pubmed-article:8643104pubmed:issnTypePrintlld:pubmed
pubmed-article:8643104pubmed:volume32lld:pubmed
pubmed-article:8643104pubmed:ownerNLMlld:pubmed
pubmed-article:8643104pubmed:authorsCompleteYlld:pubmed
pubmed-article:8643104pubmed:pagination1345-53lld:pubmed
pubmed-article:8643104pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:meshHeadingpubmed-meshheading:8643104-...lld:pubmed
pubmed-article:8643104pubmed:year1995lld:pubmed
pubmed-article:8643104pubmed:articleTitleTwo kappa immunoglobulin light chains are secreted by an anti-DNA hybridoma: implications for isotypic exclusion.lld:pubmed
pubmed-article:8643104pubmed:affiliationDepartment of Medicine, Veteran's Affairs Medical Center, Sepulveda, CA 91343, USA.lld:pubmed
pubmed-article:8643104pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8643104pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8643104pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed